Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|GO-203-2C||GO-203-2C is a small peptide that binds to mucin (MUC1) at cell membrane, thereby blocking mucin homodimerization and downstream signaling, which leads to antitumor effects (PMID: 26267657).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|
|NCT02204085||Phase Ib/II||GO-203-2C||A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia||Active, not recruiting|